Tredje AP fonden Buys 45,940 Shares of Baxter International Inc. $BAX

Tredje AP fonden boosted its stake in Baxter International Inc. (NYSE:BAX) by 62.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 119,622 shares of the medical instruments supplier’s stock after purchasing an additional 45,940 shares during the quarter. Tredje AP fonden’s holdings in Baxter International were worth $2,724,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in BAX. Creative Financial Designs Inc. ADV increased its position in Baxter International by 169.6% in the 2nd quarter. Creative Financial Designs Inc. ADV now owns 984 shares of the medical instruments supplier’s stock valued at $30,000 after buying an additional 619 shares in the last quarter. CoreFirst Bank & Trust bought a new stake in shares of Baxter International during the second quarter valued at approximately $27,000. MTM Investment Management LLC acquired a new position in shares of Baxter International during the second quarter worth approximately $30,000. CYBER HORNET ETFs LLC bought a new position in shares of Baxter International in the 2nd quarter worth $40,000. Finally, Whittier Trust Co. grew its position in Baxter International by 82.2% in the 2nd quarter. Whittier Trust Co. now owns 3,202 shares of the medical instruments supplier’s stock valued at $97,000 after purchasing an additional 1,445 shares during the period. Institutional investors own 90.19% of the company’s stock.

Wall Street Analyst Weigh In

BAX has been the topic of several research reports. Evercore lowered their price objective on shares of Baxter International from $24.00 to $23.00 in a report on Monday, January 5th. Wells Fargo & Company dropped their price target on shares of Baxter International from $21.00 to $19.00 and set an “equal weight” rating on the stock in a research report on Friday, December 12th. JPMorgan Chase & Co. decreased their price objective on Baxter International from $25.00 to $19.00 in a report on Friday, October 31st. Wall Street Zen lowered Baxter International from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Finally, UBS Group decreased their price target on Baxter International from $24.00 to $21.00 and set a “neutral” rating for the company in a report on Friday, October 31st. Two analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Reduce” and an average target price of $20.10.

Baxter International Stock Performance

BAX stock opened at $21.59 on Friday. The company has a quick ratio of 1.56, a current ratio of 2.31 and a debt-to-equity ratio of 1.55. The firm has a market cap of $11.11 billion, a PE ratio of -11.67, a P/E/G ratio of 1.50 and a beta of 0.59. The business has a 50 day moving average of $20.05 and a 200-day moving average of $21.13. Baxter International Inc. has a 12-month low of $17.40 and a 12-month high of $37.74.

Baxter International (NYSE:BAX) last posted its quarterly earnings data on Thursday, February 12th. The medical instruments supplier reported $0.44 earnings per share for the quarter, missing the consensus estimate of $0.53 by ($0.09). Baxter International had a positive return on equity of 16.95% and a negative net margin of 8.51%.The business had revenue of $2.97 billion during the quarter, compared to analysts’ expectations of $2.82 billion. During the same period in the prior year, the firm posted $0.58 EPS. The firm’s revenue for the quarter was up 8.0% on a year-over-year basis. Baxter International has set its FY 2026 guidance at 1.850-2.050 EPS. As a group, sell-side analysts expect that Baxter International Inc. will post 2.48 earnings per share for the current year.

Baxter International Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Friday, February 27th will be issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, February 27th. Baxter International’s dividend payout ratio (DPR) is -2.16%.

About Baxter International

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company’s primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter’s offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.